Between approximately May and September, 2012, the New England Compounding Center (NECC) distributed three lots of preservative-free methylprednisolone acetate (MPA) to approximately 76 out-patient surgery centers in 20 different states. The Centers for Disease Control and Prevention (CDC), in collaboration with state and local health departments and the Food and Drug Administration (FDA), continues to investigate and monitor a multistate outbreak of fungal meningitis and other infections among patients who received contaminated preservative-free MPA steroid injections from these three lots.
Both the CDC and FDA have dedicated websites that provide updated information about the outbreak and about NECC:
The FBI, the FDA’s Office of Criminal Investigations, and other federal agencies opened a criminal investigation of NECC in October 2012. The FBI is concerned about the devastating impact the outbreak has had on victims and their families. Providing information and assistance to victims is an important part of our work.